Phase
Condition
Stress
Vascular Diseases
Williams Syndrome
Treatment
ACE Inhibitors and Diuretics
NIFEdipine ER
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Postpartum women at ≥ 18 years of age
Postpartum diagnosis of persistent hypertension (2 measurements of Systolic BP ≥150and/or diastolic BP ≥ 100 or systolic BP ≥140 and/or diastolic BP ≥ 90 for peoplewith diabetes) requiring an oral medication based on the ACOG criteria or
Hypertensive disorder of pregnancy diagnosed antepartum or intrapartum requiringblood pressure medication in the postpartum
Chronic hypertension requiring blood pressure medication postpartum
Exclusion
Exclusion Criteria:
Urine output < 30 cc/h prior to screening for eligibility
Creatinine > 1.4 during current admission
End-stage renal disease
Hypersensitivity to ACE inhibitors or sulfa drugs
Idiopathic/hereditary angioedema
Hyperkalemia (serum potassium >5 mEq/L) during current admission
Pulmonary edema
Study Design
Study Description
Connect with a study center
University of Texas Health Science Center
Houston, Texas 77030
United StatesSite Not Available
University of Texas Health Science Center
Houston 4699066, Texas 4736286 77030
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.